{"created":"2020-08-30T20:05:47.929982+00:00","id":3177,"links":{},"metadata":{"_buckets":{"deposit":"09a98c86-d8aa-44c1-88c6-db5139a9a570"},"_deposit":{"id":"3177","owners":[],"pid":{"revision_id":0,"type":"recid","value":"3177"},"status":"published"},"_oai":{"id":"oai:meral.edu.mm:recid/3177","sets":["1582963366982:1596631630241"]},"communities":["um1"],"item_1583103067471":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_1551255647225":"Arterial thrombosis in Hb E - beta thalassaemia intermedia patients at Yangon General Hospital","subitem_1551255648112":""}]},"item_1583103085720":{"attribute_name":"Description","attribute_value_mlt":[{"interim":"
Thalassaemia intermedia (TI) patients are extremely diverse in phenotypic expression and there is a wide variation in clinical complications1. Thromboembolic events are among the clinical complications of TI that were found to occur at a higher rate than in patients with thalassaemia major (TM)2, 3. Hb E beta-thalassaemia disease is the commonest of the thalassaemia syndromes
\npresenting with clinical symptoms of anaemia in Myanmar4, 5. The incidence of thromboembolic events in Myanmar Hb E beta - TI patients has never been reported.